Read + Share
Amedeo Smart
Independent Medical Education
Yu C, Luo D, Yu J, Zhang M, et al. Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance in KRAS mutant colon cancer. Oncogene 2021 Oct 30. pii: 10.1038/s41388-021-02077.PMID: 34718347
Email
LinkedIn
Facebook
Twitter
Privacy Policy